These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 31314675)
1. A predicted Nau GJ; Horzempa J; O'Dee D; Brown MJ; Russo BC; Hernandez A; Dillon ST; Cheng J; Kane LP; Sanker S; Hukriede NA Virulence; 2019 Dec; 10(1):643-656. PubMed ID: 31314675 [TBL] [Abstract][Full Text] [Related]
2. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence. Russo BC; Horzempa J; O'Dee DM; Schmitt DM; Brown MJ; Carlson PE; Xavier RJ; Nau GJ Infect Immun; 2011 Sep; 79(9):3665-76. PubMed ID: 21670171 [TBL] [Abstract][Full Text] [Related]
3. A study of innate immune kinetics reveals a role for a chloride transporter in a virulent Francisella tularensis type B strain. Matz LM; Petrosino JF Microbiologyopen; 2021 Feb; 10(2):e1170. PubMed ID: 33970545 [TBL] [Abstract][Full Text] [Related]
4. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity. Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403 [TBL] [Abstract][Full Text] [Related]
6. OpiA, a Type Six Secretion System Substrate, Localizes to the Cell Pole and Plays a Role in Bacterial Growth and Viability in Cantlay S; Haggerty K; Horzempa J J Bacteriol; 2020 Jun; 202(14):. PubMed ID: 32366588 [No Abstract] [Full Text] [Related]
7. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge. Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859 [TBL] [Abstract][Full Text] [Related]
8. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent Jia Q; Horwitz MA Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510 [No Abstract] [Full Text] [Related]
10. A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence. Forestal CA; Gil H; Monfett M; Noah CE; Platz GJ; Thanassi DG; Benach JL; Furie MB Microb Pathog; 2008 Jun; 44(6):512-23. PubMed ID: 18304778 [TBL] [Abstract][Full Text] [Related]
11. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia. Golovliov I; Twine SM; Shen H; Sjostedt A; Conlan W PLoS One; 2013; 8(11):e78671. PubMed ID: 24236032 [TBL] [Abstract][Full Text] [Related]
12. Repression of inflammasome by Francisella tularensis during early stages of infection. Dotson RJ; Rabadi SM; Westcott EL; Bradley S; Catlett SV; Banik S; Harton JA; Bakshi CS; Malik M J Biol Chem; 2013 Aug; 288(33):23844-57. PubMed ID: 23821549 [TBL] [Abstract][Full Text] [Related]
13. Global transcriptional response to mammalian temperature provides new insight into Francisella tularensis pathogenesis. Horzempa J; Carlson PE; O'Dee DM; Shanks RM; Nau GJ BMC Microbiol; 2008 Oct; 8():172. PubMed ID: 18842136 [TBL] [Abstract][Full Text] [Related]
14. Deletion of IglH in virulent Francisella tularensis subsp. holarctica FSC200 strain results in attenuation and provides protection against the challenge with the parental strain. Straskova A; Cerveny L; Spidlova P; Dankova V; Belcic D; Santic M; Stulik J Microbes Infect; 2012 Feb; 14(2):177-87. PubMed ID: 21930232 [TBL] [Abstract][Full Text] [Related]
15. Construction and characterization of an attenuated purine auxotroph in a Francisella tularensis live vaccine strain. Pechous R; Celli J; Penoske R; Hayes SF; Frank DW; Zahrt TC Infect Immun; 2006 Aug; 74(8):4452-61. PubMed ID: 16861631 [TBL] [Abstract][Full Text] [Related]
16. Köppen K; Fatykhova D; Holland G; Rauch J; Tappe D; Graff M; Rydzewski K; Hocke AC; Hippenstiel S; Heuner K Front Cell Infect Microbiol; 2023; 13():1224356. PubMed ID: 37492528 [TBL] [Abstract][Full Text] [Related]
17. A method for functional trans-complementation of intracellular Francisella tularensis. Steele S; Taft-Benz S; Kawula T PLoS One; 2014; 9(2):e88194. PubMed ID: 24505427 [TBL] [Abstract][Full Text] [Related]
18. Identification of a live attenuated vaccine candidate for tularemia prophylaxis. Mahawar M; Rabadi SM; Banik S; Catlett SV; Metzger DW; Malik M; Bakshi CS PLoS One; 2013; 8(4):e61539. PubMed ID: 23613871 [TBL] [Abstract][Full Text] [Related]
19. A human macrophage-hepatocyte co-culture model for comparative studies of infection and replication of Francisella tularensis LVS strain and subspecies holarctica and mediasiatica. Rennert K; Otto P; Funke H; Huber O; Tomaso H; Mosig AS BMC Microbiol; 2016 Jan; 16():2. PubMed ID: 26739172 [TBL] [Abstract][Full Text] [Related]
20. Outer membrane vesicle-associated lipase FtlA enhances cellular invasion and virulence in Francisella tularensis LVS. Chen F; Cui G; Wang S; Nair MKM; He L; Qi X; Han X; Zhang H; Zhang JR; Su J Emerg Microbes Infect; 2017 Jul; 6(7):e66. PubMed ID: 28745311 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]